BMO Capital Markets reiterated their outperform rating on shares of Monsanto Co. (NYSE:MON) in a research report report published on Saturday morning. BMO Capital Markets currently has a $128.00 price objective on the stock.

Several other analysts also recently weighed in on the stock. S&P Equity Research reaffirmed a positive rating on shares of Monsanto in a research note on Thursday, September 15th. JPMorgan Chase & Co. reaffirmed a hold rating on shares of Monsanto in a research note on Thursday, June 30th. Monness Crespi & Hardt decreased their price target on shares of Monsanto from $130.00 to $128.00 and set a buy rating for the company in a research note on Monday, October 3rd. Zacks Investment Research downgraded shares of Monsanto from a hold rating to a sell rating in a research note on Friday, July 1st. Finally, Vetr raised shares of Monsanto from a buy rating to a strong-buy rating and set a $117.09 price target for the company in a research note on Wednesday, August 3rd. Three analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of Buy and a consensus price target of $114.67.

Analyst Recommendations for Monsanto (NYSE:MON)

Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm’s 50-day moving average price is $104.86 and its 200 day moving average price is $101.43. The stock has a market capitalization of $45.23 billion, a P/E ratio of 45.49 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The business earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.19) earnings per share. Analysts expect that Monsanto will post $4.89 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is currently 71.05%.

In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction dated Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its position in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its position in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Carnick & Kubik LLC bought a new position in Monsanto during the first quarter valued at $130,000. Institutional investors and hedge funds own 79.02% of the company’s stock.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.